Omega Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,612 | $2,134 | $2,360 | $989 |
Gross Profit | 2,612 | -7,206 | 544 | -792 |
EBITDA | -16,420 | -15,967 | -18,313 | -18,433 |
EBIT | -16,580 | -20,129 | -20,214 | |
Net Income | -16,444 | -16,305 | -20,129 | -20,214 |
Net Change In Cash | 2,612 | 2,134 | 2,360 | 989 |
Free Cash Flow | -14,031 | -13,068 | -12,340 | -18,201 |
Cash | 30,377 | 45,852 | 60,033 | 68,443 |
Basic Shares | 55,155 | 55,150 | 55,150 | 55,143 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $3,094 | $2,073 | $144 | $0 |
Gross Profit | -62,775 | 2,073 | -1,243 | -1,146 |
EBITDA | -93,490 | -97,576 | -64,644 | -27,499 |
EBIT | -100,261 | -102,766 | -66,031 | -28,645 |
Net Income | -97,428 | -102,636 | -69,162 | -30,199 |
Net Change In Cash | 3,094 | 2,073 | 144 | 0 |
Cost of Revenue | -115,867 | 163,531 | ||
Free Cash Flow | -94,379 | -99,895 | -59,076 | -27,941 |
Cash | 68,443 | 70,615 | 186,482 | 22,951 |
Basic Shares | 54,010 | 47,880 | 47,793 | 47,835 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.30 |
2024-06-30 | -$0.30 |
2024-03-31 | -$0.36 |
2023-12-31 | -$0.37 |
